Sequencing Reagents Market to Hit USD 15.34 Billion By 2031, Due to the Rising Demand of Genomics Research and Personalized Medicine, says Growth Plus Reports

Newark, New Castle, USA, April 05, 2023 (GLOBE NEWSWIRE) — According to a recent Growth Plus Reports study, the sequencing reagents market is estimated to hit US$ 15.34 billion by 2030, with a revenue CAGR of 12.70%. The study examines the important strategies, drivers and prospects, competitive circumstances, shifting market dynamics, market size, data and forecasts, and important investment regions.

Key Takeaways:

• The increasing affordability of sequencing technologies will drive market revenue growth.
• The increasing need for agricultural genomics research will drive demand for sequencing reagents.
• North America will dominate the global sequencing reagents market. 

Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/sequencing-reagents-market/8477

                                            Sequencing Reagents Market Scope

Market Drivers
The growing demand for genomics research and personalized medicine drives the demand for sequencing reagents. Furthermore, sequencing technology’s increasing availability and affordability and the growing use of sequencing reagents in clinical diagnostics are expected to boost the market revenue growth rate. The rising demand for agricultural genomics research will support the market’s revenue growth.

Market Segmentation
Growth Plus Reports has analyzed the global sequencing reagents market from four perspectives: Technology, Type, Application, End User, and Region.

Technology Segmentation: Based on the technology, the sequencing reagents market is segmented into sanger sequencing, next-generation sequencing, and third-generation sequencing. The next-generation sequencing segment dominates the market with the largest revenue share because it is a standard practice in molecular diagnostics, molecular pathology, and other clinical research applications and has low costs and enhanced throughput capabilities.

Type Segmentation: Based on the type, the sequencing reagents market is segmented into library kits, template kits, control kits, sequencing kits, and others. The sequencing kits segment dominates the market with the largest revenue share because it is a crucial component for next-generation sequencing (NGS), a high-throughput approach for determining the sequence of DNA or RNA molecules.

Application Segmentation: Based on the application, the sequencing reagents market is segmented into oncology, reproductive health, clinical investigation, Agri genomics & forensics, and others. The oncology segment leads the market because of the growing need for novel medications and clinical trials to deliver better and more effective cancer treatment.

End-User Segmentation: Based on the end-user, the sequencing reagents market is segmented into academic research, clinical research, hospitals & clinics, pharmaceutical & biotechnology companies, and others. The clinical research segment dominates the market because of the increasing use of CLIA-waived or clinically approved high throughput diagnostic tests.

Regional Growth Dynamics
Based on the region, the global sequencing reagents market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America leads the sequencing reagents market with the largest revenue share. Increased commercial sales, government financing, increased sequencing research efforts, rising public, corporate, and government investment in sequencing research, advanced R&D infrastructure, and the increasing chronic illness burden are responsible for North America’s significant revenue share.  

Request for Customization – https://www.growthplusreports.com/inquiry/customization/sequencing-reagents-market/8477

Competitive Landscape

The key players in the global sequencing reagents market are:

· F. Hoffmann-La Roche AG
· Thermo Fisher Scientific Inc.
· Illumina Inc.
· QIAGEN
· BGI
· Pacific Biosciences of California Inc.
· Oxford Nanopore Technologies
· Agilent Technologies Inc.
· Fluidigm Corporation
· ArcherDX Inc.
· Takara Bio Inc.

The market for sequencing reagents is moderately competitive, with several multinational companies. Major competitors engage in technological advancements, R&D, and mergers and acquisitions to enhance their market position.

Recent developments:

• QIAGEN N.V. introduced the QIAseq DIRECT SARS-CoV-2 Kit in April 2021, a viral genome enrichment and library preparation solution that considerably reduces library turnaround times and plastics consumption compared to ARTIC project methods.

• Agilent Technologies launched a new library preparation system for NGS technology named Magnis NGS Prep System in March 2019. This new system comprises reagents and protocols that make it simple to detect complex genetic aberrations and several genes in genomic DNA.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints
   3. Opportunities
5. GLOBAL SEQUENCING REAGENTS MARKET- ANALYSIS & FORECAST, BY TECHNOLOGY
   1. Sanger Sequencing
   2. Next-Generation Sequencing
   3. Third-Generation Sequencing
6. GLOBAL SEQUENCING REAGENTS MARKET- ANALYSIS & FORECAST, BY TYPE-
   1. Library Kits
   2. Template Kits
   3. Control Kits
   4. Sequencing Kits
   5. Others

SEQUENCING REAGENTS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8477

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse related reports:

Enteral Feeding Devices Market by Product (Enteral Feeding Pumps, Enteral Feeding Tubes, Enterostomy Feeding Tubes, Nasoenteric Feeding Tubes), Age Group (Pediatrics, Adults) Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care), End User (Hospitals & Home Care) – Global Outlook & Forecast 2023-2031

Drug Repurposing Market by Type (Disease-centric approach, Target-centric approach), Therapeutic Area (Same Therapeutic Area, Different Therapeutic Area), Drug Molecule (Biologics, Small Molecule) – Global Outlook & Forecast 2023-2031

Digital Pathology Market by Product (Scanners, Software), Application (Drug Discovery, Disease Diagnostics), End User (Hospitals, Diagnostic Labs) – Global Outlook & Forecast 2023-2031

Crohn’s Disease Treatment Market by Type (Ileocolitis, Ileitis), Drug Type (Antibiotics, Amino Salicylates), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy) – Global Outlook & Forecast 2023-2031

Biologics Contract Manufacturing Market by Product (Recombinant Proteins, Monoclonal Antibodies), Indication (Oncology, Cardiology) – Global Outlook and Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.